Skip to main content

Advertisement

Log in

Vitamin D association with estradiol and progesterone in young women

  • Brief report
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective

Vitamin D may reduce breast cancer risk through an effect on steroid hormones in cycling women. We conducted a study to determine whether there is an association between circulating 25-hydroxyvitamin D (25(OH)D) and estradiol and progesterone in young women.

Methods

Volunteer women aged 18–22 and not using hormonal contraceptives were recruited during summer and winter. They provided demographic and lifestyle information and a blood sample. Women recruited in winter gave a second sample after taking vitamin D supplement for 4 weeks. There were 101 women sampled during the luteal phase (1–14 days prior to the start of the next menstrual period). Generalized estimating equation linear regression models were used to examine the relationship between 25(OH)D and estradiol and progesterone.

Results

Per increase of 10 nmol/l of 25(OH)D, progesterone multiplicatively decreased by a factor of 10% (95% CI 5–14%, p < 0.001) and estradiol decreased by a factor of 3% (95% CI 0–6%, p = 0.04) after adjustment for age, body mass index, ethnicity, season, alcohol use, smoking, and physical activity.

Conclusions

Higher levels of vitamin D may reduce progesterone and estradiol, providing a potential mechanism for reduction in breast cancer risk from increased vitamin D exposure in young women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. IARC (2008) Vitamin D and cancer. IARC working group reports, vol 5. International Agency for Research on Cancer, Lyon

  2. Chlebowski RT, Johnson KC, Kooperberg C et al (2008) Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100:1581–1591

    Article  CAS  PubMed  Google Scholar 

  3. Speers C, Brown P (2008) Breast cancer prevention using calcium and vitamin D: a bright future? J Natl Cancer Inst 100:1562–1564

    Article  CAS  PubMed  Google Scholar 

  4. Knight JA, Lesosky M, Barnett H, Raboud J, Vieth R (2007) Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 16:422–429

    Article  CAS  PubMed  Google Scholar 

  5. Sahota H, Barnett H, Lesosky M, Raboud J, Vieth R, Knight JA (2008) The association of vitamin D related information from a telephone interview with 25-hydroxyvitamin D. Cancer Epidemiol Biomarkers Prev 17:232–238

    Article  CAS  PubMed  Google Scholar 

  6. Halloran B, Deluca HF (1980) Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J Nutr 110:1573–1580

    CAS  PubMed  Google Scholar 

  7. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y (2000) Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 141:1317–1324

    Article  CAS  PubMed  Google Scholar 

  8. Horii I, Takizawa S, Fujii T (1992) Effect of 1, 25-dihydroxyvitamin D3 on the female reproductive system in rats. J Toxicol Sci 17:91–105

    CAS  PubMed  Google Scholar 

  9. Barger-Lux MJ, Heaney RP (2002) Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 87:4952–4956

    Article  PubMed  Google Scholar 

  10. Diggle PJ, Liang K-Y, Zeger SL (1994) Analysis of longitudinal data. Oxford University Press, New York

    Google Scholar 

  11. Wathen NC, Perry L, Lilford RJ, Chard T (1984) Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J 288:7–9

    Article  CAS  Google Scholar 

  12. Jeffcoate SL (1984) Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J 288:864

    Article  CAS  Google Scholar 

  13. Berek JS (ed) (2007) Berek and Novak’s gynecology, 14th edn. Lippincott Williams and Wilkins, Philadelphia, p 1208

    Google Scholar 

  14. Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17–35

    CAS  PubMed  Google Scholar 

  15. Bernstein L, Ross RK, Lobo RA, Hanisch R, Krailo MD, Henderson BE (1987) The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br J Cancer 55:681–685

    CAS  PubMed  Google Scholar 

  16. Maskarinec G, Morimoto Y, Novotny R, Nordt FJ, Stanczyk FZ, Franke AA (2005) Urinary sex steroid secretion levels during a soy intervention among young girls: a pilot study. Nutr Cancer 52:22–28

    Article  CAS  PubMed  Google Scholar 

  17. Chavarro JE, Rich-Edwards JW, Rosner B, Willett WC (2007) A prospective study of dairy foods intake and anovulatory infertility. Hum Reprod 22:1340–1347

    Article  CAS  PubMed  Google Scholar 

  18. Pérez-Fernandez R, Alonso M, Segura C, Muñoz I, García-Caballero T, Diéguez C (1997) Vitamin D receptor gene expression in human pituitary gland. Life Sci 60:35–42

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julia A. Knight.

Additional information

Financial support: Canadian Breast Cancer Foundation Ontario Division.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knight, J.A., Wong, J., Blackmore, K.M. et al. Vitamin D association with estradiol and progesterone in young women. Cancer Causes Control 21, 479–483 (2010). https://doi.org/10.1007/s10552-009-9466-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-009-9466-0

Keywords

Navigation